GlassScriptPhysician profile
Michael B Esposito
NPI 1205827672
$16,291.34
in general payments reported to CMS, 2019-2025
13 companies · $221 in 2025
The $221 reported for 2025 was more than what a typical Diagnostic Neuroimaging (Radiology) provider received nationally (typical 2025 total: $109).
See the full distribution for Diagnostic Neuroimaging (Radiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,261 · 2020: $2,307 · 2021: $6,977 · 2022: $713 · 2023: $390 · 2024: $423 · 2025: $221.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $859 · Education: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $858.90 |
| Education | $175.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $12,329.91 | 2019-2021 | |
| Boston Scientific Corporation | $1,328.86 | 2020-2025 | General - Pain Management, Wavewriter Alpha Prime 16 |
| Nevro Corp. | $1,250.04 | 2019-2021 | |
| Vertos Medical, INC. | $642.74 | 2021-2024 | Mild Device Kit |
| Curonix LLC | $205.98 | 2023-2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Cms Imaging, INC. | $180.11 | 2021-2022 | |
| Imperative Care, INC | $116.20 | 2024 | Symphony Catheter |
| Painteq LLC | $76.82 | 2021 | |
| Siemens Medical Solutions USA, INC. | $60.51 | 2025 | Mobilett Elara Max |
| Stimwave Technologies Incorporated | $50.42 | 2021-2022 | |
| Biohaven Pharmaceuticals, INC. | $18.47 | 2021 | |
| Medtronic, INC. | $17.08 | 2025 | Interstim |
| Ge Healthcare | $14.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Esposito listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.